Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 September 2020 | Story Leonie Bolleurs | Photo Supplied
Participants in the third Amazing Race travelled through the African continent, experiencing Africa’s roots and its rich, vibrant, and diverse cultures

During the third Amazing Race presented by Organisational Development and Employee Wellness, staff had the opportunity to virtually travel through Africa. 

The aim of the race with the theme, A Journey through Africa, was to celebrate South Africa and Africa’s roots and its rich, vibrant, and diverse cultures. 

Natasha Nel, organisational development specialist and organiser of the race, says they wanted to give the 13 participating teams the opportunity to explore, learn, create, and be challenged together as they travel to some of the most interesting and exotic locations around Africa, but also in South Africa. 

Here in our own country, teams had the opportunity to experience our culture as well as the diversity of beliefs and traditions.


Here in our own country, teams had the opportunity to experience our culture as well as the diversity of beliefs and traditions.

Interactive and exciting event

Nel says staff could join the race in the convenience of their personal working space via a Zoom meeting. “They only needed to download the game that was specifically tailored for the UFS.” 

“It was a fun, interactive, and exciting event. In this unique adventure, it was interesting to see how teams worked together, made decisions, and also thought outside the box during the challenges,” she says.

Nel explains that teams were requested to take photos, answer questions, and make decisions unique to Africa and their culture. Some decisions and answers were timed. They also had to decide where they wanted to travel, but each decision and option had its costs, reward, and challenge linked to it.

We are the champions

Chanel Lewis, Aneke Kruger, Runé van der Merwe, and Lischen du Randt walked away as winners of the third Amazing Race. 

By participating in this race, the university has sponsored 13 breakfasts for the Community Chest of South Africa (this organisation’s mission is to inspire and facilitate community giving for community enhancement).


News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept